nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adrenal crises in older patients
|
Rushworth, Ruth L |
|
|
8 |
7 |
p. 628-639 |
artikel |
2 |
Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery
|
Rubino, Francesco |
|
|
8 |
7 |
p. 640-648 |
artikel |
3 |
Causes, consequences, and treatment of metabolically unhealthy fat distribution
|
Stefan, Norbert |
|
|
8 |
7 |
p. 616-627 |
artikel |
4 |
Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study
|
Groeneweg, Stefan |
|
|
8 |
7 |
p. 594-605 |
artikel |
5 |
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
|
Cherney, David Z I |
|
|
8 |
7 |
p. 582-593 |
artikel |
6 |
Gestational diabetes and fetal overgrowth: time to rethink screening guidelines
|
Chiefari, Eusebio |
|
|
8 |
7 |
p. 561-562 |
artikel |
7 |
Guy T'Sjoen: collaborating to improve transgender wellbeing
|
Mitchell, Fiona |
|
|
8 |
7 |
p. 568 |
artikel |
8 |
Health care and mental health challenges for transgender individuals during the COVID-19 pandemic
|
Wang, Yuanyuan |
|
|
8 |
7 |
p. 564-565 |
artikel |
9 |
How diabetes management is adapting amid the COVID-19 pandemic
|
Ranscombe, Peter |
|
|
8 |
7 |
p. 571 |
artikel |
10 |
Is maternal obesity a risk factor for rare childhood cardiovascular diseases?
|
Gaillard, Romy |
|
|
8 |
7 |
p. 552-553 |
artikel |
11 |
Lose the weight in your head
|
Stirrups, Robert |
|
|
8 |
7 |
p. 569 |
artikel |
12 |
Maternal obesity and risk of cardiovascular diseases in offspring: a population-based cohort and sibling-controlled study
|
Razaz, Neda |
|
|
8 |
7 |
p. 572-581 |
artikel |
13 |
Maturity-onset diabetes of the young (MODY): a time to act
|
Al-Kandari, Hessa |
|
|
8 |
7 |
p. 565-566 |
artikel |
14 |
MCT8 deficiency: collaborative rare disease phenotyping for care and research
|
Wassner, Ari J |
|
|
8 |
7 |
p. 555-557 |
artikel |
15 |
Oh sugar! How diabetes campaigns can be damaging to the cause they aim to serve
|
Speight, Jane |
|
|
8 |
7 |
p. 566-567 |
artikel |
16 |
Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials
|
Gerstein, Hertzel C |
|
|
8 |
7 |
p. 557-558 |
artikel |
17 |
Prevalence of obesity among adult inpatients with COVID-19 in France
|
Caussy, Cyrielle |
|
|
8 |
7 |
p. 562-564 |
artikel |
18 |
Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?
|
Sternlicht, Hillel K |
|
|
8 |
7 |
p. 553-555 |
artikel |
19 |
Relating to transgender issues
|
Stirrups, Robert |
|
|
8 |
7 |
p. 569 |
artikel |
20 |
Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study
|
Kohsaka, Shun |
|
|
8 |
7 |
p. 606-615 |
artikel |
21 |
Technology in the COVID-19 era: pushing the boundaries
|
The Lancet Diabetes & Endocrinology, |
|
|
8 |
7 |
p. 551 |
artikel |
22 |
Vitamin-D and COVID-19: do deficient risk a poorer outcome?
|
Mitchell, Fiona |
|
|
8 |
7 |
p. 570 |
artikel |
23 |
Walking the path together: incorporating Indigenous knowledge in diabetes research
|
Maple-Brown, Louise J |
|
|
8 |
7 |
p. 559-560 |
artikel |